Robin Feldman on Drug Manufacturers’ Abuse of the Citizen-Petition Process
Soaring healthcare prices currently threaten the viability of our healthcare system and the overall economy. U.S. healthcare spending, both per capita and as a percentage of GDP, far outpaces spending by any other high-income country, without corresponding increases in quality or access to care. Pharmaceutical drug prices, a component of overall healthcare spending, have dramatically… Continue reading Robin Feldman on Drug Manufacturers’ Abuse of the Citizen-Petition Process